证券代码：688800 证券简称：瑞可达 公告编号：2025-046 苏州瑞可达连接系统股份有限公司 第四届监事会第二十一次会议决议公告 本公司监事会及全体监事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 监事会认为：公司2025年半年度报告及摘要的编制和审议程序符合法律法规、 《公司章程》和公司内部管理制度的各项规定。公司2025年半年度报告的内容与 格式符合中国证券监督管理委员会和上海证券交易所的各项规定，能够公允反映 公司报告期内的财务状况和经营成果。我们保证公司2025年半年度报告披露的信 息真实、准确、完整，不存在任何虚假记载、误导性陈述或重大遗漏，并对其内 容的真实性、准确性和完整性依法承担法律责任。 具体内容详见公司同日在上海证券交易所网站（www.sse.com.cn）披露的 《2025年半年度报告》及其摘要。 表决结果：同意 3 票，反对 0 票，弃权 0 票。 （二）审议通过《关于2025年半年度募集资金存放、管理与实际使用情况的 专项报告的议案》 监事会认为：公司 2025 年半年度募集资金存放、管理与实际使用情况符合 《 ...

股票代码：600258 股票简称：首旅酒店 编号：临 2025-036 北京首旅酒店（集团）股份有限公司 2025 年上半年 募集资金存放与实际使用情况专项报告的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 北京首旅酒店（集团）股份有限公司（以下简称"公司"）严格遵守上市公 司募集资金管理和使用的监管要求，按照《北京首旅酒店(集团)股份有限公司募 集资金管理及使用办法》的内部控制制度执行，全面做好公司募集资金存放和使 用，2025 年上半年募集资金存放与实际使用情况专项报告如下。 一、募集资金基本情况 根 据 中 国 证 券 监 督 管 理 委 员 会 于 2021 年 10 月 18 日 签 发 的 证 监 许 可 [2021]3299 号文《关于核准北京首旅酒店(集团)股份有限公司非公开发行股票 的批复》，公司获准向特定投资者非公开发行人民币普通股 134,348,410 股，每 股发行价格为人民币 22.33 元，股款以人民币缴足，募集资金总额为人民币 增值税)后，实际收到的募集资金为人民币 2,994,275, ...

证券代码：600283 证券简称：钱江水利 公告编号：临 2025-034 钱江水利开发股份有限公司 关于部分募投项目结项并将节余募集资金 用于其他募投项目的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 本次拟结项募投项目："胡村水厂工程（一期）项目""兰溪市登胜水厂工 程项目""福州江阴港城经济区污水处理厂中期工程特许经营项目（一期）""常 山华侨城污水处理厂扩建及提标改造工程特许经营项目"。 ? 剩余募集资金安排：节余募集资金 10,685.60 万元（实际金额以扣除应付未 付金额后，资金转出当日专户余额为准）用于尚未完工的募投项目"永康市城市污 水处理厂（五期）工程项目"和"平湖市独山港区工业水厂三期工程项目"。 钱江水利开发股份有限公司（以下简称"公司"）于 2025 年 8 月 27 日召开第八届 董事会第十次会议，审议通过《关于部分募投项目结项并将节余募集资金用于其他募投 项目的议案》，同意公司将"胡村水厂工程（一期）项目""兰溪市登胜水厂工程项目" "福州江阴港城经济区污水处理厂中期工 ...

本公司董事会及全体董事保证本公告内容不存在任何 虚假记载、误导性陈述或重大遗漏,并对其内容的真实性、准 确性和完整性承担法律责任。 一、 募集资金基本情况 （一） 募集资金金额及到位时间 经中国证券监督管理委员会《关于同意钱江水利开发股 份有限公司向特定对象发行股票注册的批复》（证监许可 〔2024〕1293 号）同意注册，钱江水利开发股份有限公司（以 下简称"本公司"或"钱江水利"）向特定对象发行普通股 币 8.72 元，募集资金总额为人民币 581,020,898.64 元，扣 除发行费用人民币 8,650,266.16 元（不含增值税）后，募集 资金净额为人民币 572,370,632.48 元。 上述募集资金已于 2024 年 12 月 2 日全部存入本公司账 户，天健会计师事务所（特殊普通合伙）对本次发行的认购 缴存到位情况进行了审验，并于 2024 年 12 月 3 日出具了 《验资报告》（天健验〔2024〕491 号）。为了规范募集资金 管理，保护投资者的合法权益，本公司及实施募集资金投资 项目的子公司与募集资金专户开户银行、保荐机构签订了 《募集资金专户储存三方监管协议》及《募集资金专户储存 ...

Summary of Key Points Core Viewpoint - The company, Fujian Foxit Software Development Co., Ltd., has utilized its own funds to pay for investment projects and subsequently replaced these with equivalent amounts from raised funds, ensuring compliance with regulatory requirements and enhancing operational efficiency [1][6]. Group 1: Fundraising Overview - The company was approved to publicly issue 12.04 million shares at a price of RMB 238.53 per share, raising a total of RMB 2,871,901,200, with a net amount of RMB 2,586,478,593.67 after deducting issuance costs [1][2]. - As of June 30, 2025, the remaining balance of raised funds was RMB 437,639,800 [2]. Group 2: Investment Project Status - The total investment in various projects includes: - PDF Product R&D and Upgrade: RMB 179,070,900 (completed) - Document Intelligent Cloud Service: RMB 152,764,100 (completed) - Cutting-edge Document Technology R&D: RMB 13,835,700 (completed) - Property Purchase for Fuzhou R&D Center: RMB 42,220,000 (completed) - Permanent Supplement to Working Capital: RMB 1,306,000,000 (completed) - Global Marketing Service Network: RMB 557,800,900 (ongoing) - Intelligent Document Processing Platform: RMB 278,014,700 (ongoing) - Share Buyback: RMB 15,774,300 (completed) - Acquisition of Foxit Kunpeng Equity: RMB 90,238,100 (ongoing) [2]. Group 3: Reasons and Process for Fund Replacement - The company opted to use its own funds for initial payments due to operational efficiency and compliance with banking regulations regarding salary payments, which require the use of basic or general accounts [3][4]. - The process involves the finance manager's review, board approval, and subsequent transfer of equivalent amounts from the raised funds account to the company's basic account [5]. Group 4: Impact on Daily Operations - The use of self-funds for project payments is expected to enhance operational management efficiency and ensure the smooth progress of investment projects without affecting the normal implementation of these projects [5][6]. Group 5: Review Procedures - The board and supervisory committee approved the use of self-funds for project payments and the subsequent replacement with raised funds, confirming compliance with relevant regulations [6][7].

上海皓元医药股份有限公司 报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据《上市公司募集资金监管规则》和《上海证券交易所科创板上市公司自 律监管指引第 1 号——规范运作》（以下简称"《自律监管指引 1 号》"）的规 定，将上海皓元医药股份有限公司（以下简称"本公司"或"公司"）2025 年 半年度募集资金存放与实际使用情况报告如下： 一、募集资金基本情况 （一）2024 年度向不特定对象发行可转换公司债券实际募集资金金额和资 金到账时间 经中国证券监督管理委员会《关于同意上海皓元医药股份有限公司向不特定 对象发行可转换公司债券注册的批复》（证监许可[2024]1289号）同意，公司向不 特定对象发行82,235.00万元的可转换公司债券，期限6年，每张面值为人民币100元， 发 行 数 量为822,350 手（ 8,223,500 张）。 本次发 行的募集资 金总额 为人民 币 （特殊普通合伙）于2024年12月5日出具了《验资报告》（容诚验字[2024]200Z0069 号）。 公司对募集资金采用专户存储，设 ...

Meeting Overview - The second meeting of the second supervisory board of Jiangsu Weidao Nano Technology Co., Ltd. was held on August 28, 2025, with all three supervisors present, ensuring compliance with relevant laws and regulations [1][2]. Financial Reporting - The supervisory board approved the 2025 semi-annual report and its summary, confirming that the report accurately reflects the company's operational management and financial status for the first half of 2025 [2][3]. Fund Management - The board reviewed and approved a special report on the storage and actual use of raised funds for the first half of 2025, confirming compliance with relevant regulations and that the funds were stored and used appropriately [3][5]. - The board also approved an adjustment to the amount of raised funds allocated to investment projects, ensuring that this adjustment does not adversely affect the normal use of the funds or the interests of shareholders [5][6]. Cash Management - The company plans to use up to RMB 800 million of temporarily idle raised funds for cash management, investing in safe and liquid financial products while ensuring that this does not conflict with the investment plans [6][7]. Foreign Exchange Risk Management - The supervisory board approved the establishment of a foreign exchange hedging management system to mitigate foreign exchange market risks and authorized the company to engage in foreign exchange hedging activities with a maximum transaction amount of RMB 300 million or equivalent [7].

无锡祥生医疗科技股份有限公司 募集资金管理办法 第一章 总则 第一条 为加强、规范无锡祥生医疗科技股份有限公司(以下简称"公司")募集 资金的管理, 提高募集资金使用效率和效益, 根据《中华人民共和国公 司法》《中华人民共和国证券法》《上市公司证券发行注册管理办法》 《上市公司募集资金监管规则》 《上海证券交易所科创板上市公司自律 监管指引第 1 号——规范运作》《上海证券交易所科创板股票上市规 则》(以下简称"《上市规则》")等法律法规和规范性文件以及《无锡 祥生医疗科技股份有限公司章程》(以下简称"《公司章程》")的规定, 结合公司实际情况, 特制定本办法。 公司的董事、高级管理人员应当勤勉尽责, 确保公司募集资金安全, 不 得操控公司擅自或变相改变募集资金用途。 第五条 公司的控股股东、实际控制人及其他关联人不得占用公司募集资金, 不得利用公司募集资金投资项目(以下简称"募投项目")获取不正当利 益。 公司发现控股股东、实际控制人及其他关联人占用募集资金的, 应当 及时要求归还, 并披露占用发生的原因、对公司的影响、清偿整改方案 及整改进展情况。 第二章 募集资金存储 第七条 公司应当在募集资金到账后一 ...

Meeting Overview - The first session of the Supervisory Board's 24th meeting was held on August 27, 2025, with all five supervisors present, ensuring compliance with legal and regulatory requirements [1]. Financial Reporting - The Supervisory Board approved the 2025 semi-annual report, confirming that it accurately reflects the company's operational results and financial status, adhering to relevant regulations [2]. - The voting results for the semi-annual report were unanimous, with 5 votes in favor [2]. Fund Management - The Board approved the special report on the use of raised funds, affirming that the funds were stored and used in accordance with legal regulations, with no violations or harm to shareholder interests [2]. - The voting results for the fund management report were also unanimous, with 5 votes in favor [2]. Risk Assessment - The Board approved the continuous risk assessment report for the financial company, indicating that it has a valid financial license and a robust internal control and risk management system [3]. - The voting results for the risk assessment report were unanimous, with 5 votes in favor [3]. Asset Impairment - The Board approved the proposal for asset impairment provisions for the first half of 2025, stating that the provisions were made in accordance with accounting standards and reflect the financial situation accurately [4]. - The voting results for the asset impairment proposal were unanimous, with 5 votes in favor [4]. Cash Management - The Board approved the use of temporarily idle raised funds for cash management, ensuring that this does not affect project construction or shareholder interests [5]. - The voting results for the cash management proposal were unanimous, with 5 votes in favor [5].

Group 1 - The third extraordinary meeting of the third Supervisory Board of Shanghai Port Construction (Group) Co., Ltd. was held on August 27, 2025, via teleconference, with all three supervisors present [1][2] - The Supervisory Board approved the company's 2025 semi-annual report and summary, confirming that the financial accounting system is sound and complies with relevant laws and regulations [1][2] - The Supervisory Board also approved the special report on the storage and actual use of raised funds for the first half of 2025, stating that the company adhered to regulations regarding the management of raised funds and fulfilled necessary disclosure obligations [2]